Sunshine Biopharma (SBFM) Non Operating Income (2012 - 2026)
Sunshine Biopharma (SBFM) reported Non Operating Income of $151728.0 for Q1 2026, up 100.12% on a YoY basis from $75818.0 in Q1 2025, and up 164.07% quarter-over-quarter from $57458.0 in Q4 2025.
Sunshine Biopharma (SBFM) Non Operating Income (2012 - 2026) Analysis & Trends
Sunshine Biopharma has reported Non Operating Income for 14 years, with the latest figure at $151728.0 in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Income rose 100.12% year-over-year to $151728.0; the trailing twelve-month figure through Mar 2026 stood at $349196.0 (down 8.26% YoY), and the FY2025 full-year result was $273286.0, down 38.33% from the prior year.
- Non Operating Income for Q1 2026 stood at $151728.0, up from $57458.0 in the prior quarter.
- The five-year high for Non Operating Income was $430285.0 in Q2 2024, with the low at -$249227.0 in Q4 2024.
- Historically, Non Operating Income has averaged $118075.3 across 5 years, with a median of $123767.0 in 2024.
- Annual changes were most pronounced in 2023 — Non Operating Income soared 1442.82% — and 2024, when it sank 258.28%.
- Sunshine Biopharma's Non Operating Income stood at $84599.0 in 2022, then surged by 86.13% to $157464.0 in 2023, then slumped by 258.28% to -$249227.0 in 2024, then soared by 123.05% to $57458.0 in 2025, then surged by 164.07% to $151728.0 in 2026.
- The last three Non Operating Income figures came in at $151728.0 (Q1 2026), $57458.0 (Q4 2025), and $65355.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -216.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 20.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -7.50 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -504,111.66 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 53.40 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -13.65 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 5.71 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -23.23 Mn |
| 10 | Sunshine Biopharma | 11.70 Mn | 4.79 Mn | 2.18 Mn | 151,728.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 151,728.00 |
| Dec 31, 2025 | 57,458.00 |
| Sep 30, 2025 | 65,355.00 |
| Jun 30, 2025 | 74,655.00 |
| Mar 31, 2025 | 75,818.00 |
| Dec 31, 2024 | -249,227.00 |
| Sep 30, 2024 | 123,767.00 |
| Jun 30, 2024 | 430,285.00 |
| Mar 31, 2024 | 89,141.00 |
| Dec 31, 2023 | 157,464.00 |
| Sep 30, 2023 | 168,944.00 |
| Jun 30, 2023 | 199,457.00 |
| Mar 31, 2023 | 172,821.00 |
| Dec 31, 2022 | 84,599.00 |
| Sep 30, 2022 | 260,961.00 |
| Jun 30, 2022 | 156,924.00 |
| Mar 31, 2022 | -12,870.00 |
| Dec 31, 2021 | 946,747.00 |
| Sep 30, 2021 | -3.54 Mn |
| Jun 30, 2021 | -2.49 Mn |